Precipio Inc (NASDAQ:PRPO) achieved its goal of reaching break-even by the end of 2024, with positive adjusted EBITDA and positive cash flow. The company reported a revenue growth of nearly 26% in Q4 ...
Precipio Inc (NASDAQ:PRPO) achieved positive adjusted EBITDA of nearly $0.5 million for the first time in its history. The company generated over $0.275 million of cash from operations, marking a ...
Precipio Inc (NASDAQ:PRPO) achieved a significant milestone by crossing the 10,000 case mark for the year, up from 8,000 in 2023, indicating strong growth in their diagnostic services. The pathology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results